Events

Transparency, Aggregate Spend & HCP Engagement (8/14-8/16)

August 1st 2025

Pharma Forum (March 23-26, 2025)

December 18th 2024

Pharma USA 2025 (March 18-19, 2025)

December 18th 2024

Life Sciences Accounting & Reporting Congress (March 18-20, 2025)

December 18th 2024

Hub and Specialty Pharmacy Models East (March 18-20, 2025)

December 18th 2024

PAP – Patient Assistance & Access Programs (March 18-20, 2025)

December 18th 2024

Rare Disease Summit (March 18-20, 2025)

December 18th 2024

Speaker Programs Summit (March 3-5, 2025)

December 18th 2024

Clinical Data Disclosure, Transparency and Plain Language Summaries (Feb. 25-26, 2025)

December 18th 2024

Indegene Digital Summit 2024 (October 17-18)

October 3rd 2024

2024 Life Sciences Accounting & Reporting Congress

February 8th 2024

2024 Rare Disease Summit - 3/19-21

February 8th 2024

Pharma Forum EMEA (11/13-11/15)

May 1st 2023

Compliance Congress for Specialty Products (9/19-9/21)

May 1st 2023

Independent Medical Education & Grants Summit (9/19-9/21)

May 1st 2023

Finance & Accounting for Bioscience Companies (9/19-9/20)

May 1st 2023

Health Systems & Pharma Partnering Summit (8/14-8/16)

May 1st 2023

Pharmaceutical Compliance Congress —4/25-4/27

April 25th 2023

Pharma USA 2023 — 3/28-3/29

March 28th 2023

Pharmaceutical Compliance Congress Canada (6/6 - 6/8/23)

January 20th 2023

Drug Pricing Transparency Congress (5/16 - 5/17/23)

January 20th 2023

Medicaid & Government Pricing Congress (5/16 - 5/18/23)

January 20th 2023

Pharmaceutical Compliance Congress (4/25 - 4/27/2023)

January 20th 2023

Rare Disease Innovation & Partnership Summit (3/21 - 3/23/23)

January 20th 2023

PAP – Patient Assistance & Access Programs (3/20 - 3/22/23)

January 20th 2023

Pharma Forum (3/19 - 3/22/23)

January 20th 2023

Life Sciences Accounting & Reporting Congress (3/14 - 3/16/23)

January 20th 2023

Speaker Programs Summit (2/27 - 3/1)

January 20th 2023

Pharma 2023 Europe (4/18 - 4/19)

January 9th 2023

Pharma USA 2023 (3/28 - 3/29)

January 9th 2023

Trending on PharmExec

Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release

FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma

Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits

Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience

Events

Transparency, Aggregate Spend & HCP Engagement (8/14-8/16)

Pharma Forum (March 23-26, 2025)

Pharma USA 2025 (March 18-19, 2025)

Life Sciences Accounting & Reporting Congress (March 18-20, 2025)

Hub and Specialty Pharmacy Models East (March 18-20, 2025)

PAP – Patient Assistance & Access Programs (March 18-20, 2025)

Rare Disease Summit (March 18-20, 2025)

Speaker Programs Summit (March 3-5, 2025)

Clinical Data Disclosure, Transparency and Plain Language Summaries (Feb. 25-26, 2025)

Indegene Digital Summit 2024 (October 17-18)

2024 Life Sciences Accounting & Reporting Congress

2024 Rare Disease Summit - 3/19-21

Pharma Forum EMEA (11/13-11/15)

Compliance Congress for Specialty Products (9/19-9/21)

Independent Medical Education & Grants Summit (9/19-9/21)

Finance & Accounting for Bioscience Companies (9/19-9/20)

Health Systems & Pharma Partnering Summit (8/14-8/16)

Pharmaceutical Compliance Congress —4/25-4/27

Pharma USA 2023 — 3/28-3/29

Pharmaceutical Compliance Congress Canada (6/6 - 6/8/23)

Drug Pricing Transparency Congress (5/16 - 5/17/23)

Medicaid & Government Pricing Congress (5/16 - 5/18/23)

Pharmaceutical Compliance Congress (4/25 - 4/27/2023)

Rare Disease Innovation & Partnership Summit (3/21 - 3/23/23)

PAP – Patient Assistance & Access Programs (3/20 - 3/22/23)

Pharma Forum (3/19 - 3/22/23)

Life Sciences Accounting & Reporting Congress (3/14 - 3/16/23)

Speaker Programs Summit (2/27 - 3/1)

Pharma 2023 Europe (4/18 - 4/19)

Pharma USA 2023 (3/28 - 3/29)

Trending on PharmExec

Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release

FDA Approves GSK's Exdensur as Twice-Yearly Add-On Therapy for Severe Asthma

Four Republicans Break with House GOP to Force Vote on Extending ACA Tax Credits

Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience

Sanofi Reaches Deals with ADEL for Novel Alzheimer’s Disease Drug, Dren Bio for B-cell Depletion Therapy